This rebalancing strengthens intestinal barrier integrity, inhibits oxidative stress, and downregulates aryl hydrocarbon receptor (AhR)-mediated inflammation and renal fibrosis (70, 71). The gene discussed is AHR; the disease is renal fibrosis.